Translate to...

Q&A: New blood cancer treatment options with chimeric antigen receptor-T cell therapy

Q&A: New blood cancer treatment options with chimeric antigen receptor-T cell therapy

Dear Mayo Clinic: My brother was diagnosed with non-Hodgkin lymphoma a few years ago and has had several recurrences. I was reading about something called chimeric antigen receptor-T cell therapy (CAR-T cell therapy) and was wondering how it works and if he might be a candidate for it?